Pharmacogenomic Next-Generation DNA Sequencing: Lessons From the Identification and Functional Characterization of Variants of Unknown Significance in CYP2C9 and CYP2C19
Drug Metabolism and Disposition - United States
doi 10.1124/dmd.118.084269
Full Text
Open PDFAbstract
Available in full text
Date
February 11, 2019
Authors
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)